{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ROBERT PEAR", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "PEAR"}]}, "abstract": "Pharmaceutical industry has been shaken following move by Teva Pharmaceutical Industries, world's largest generic drug company, to join Pharmaceutical Research and Manufacturers of America, trade group representing interests of brand-name producers; move has raised alarm among lobbyists and companies facing legal battles with generic producers over drug pricing. ", "type_of_material": "News", "word_count": "1062", "lead_paragraph": "Teva Pharmaceuticals wants to join PhRMA, a powerful trade association, raising alarm among drug companies facing disputes over high prices.", "pub_date": "2016-07-01T21:27:53+0000", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Brand-Name Drug Makers Wary of Letting Generic Rival Join Their Club", "print_headline": "Drug Group Considering a Producer of Generics"}, "snippet": "Teva Pharmaceuticals wants to join PhRMA, a powerful trade association, raising alarm among drug companies facing disputes over high prices....", "multimedia": [{"height": 126, "url": "images/2016/07/02/us/02pharma/02pharma-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/07/02/us/02pharma/02pharma-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2016/07/02/us/02pharma/02pharma-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/07/02/us/02pharma/02pharma-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/07/02/us/02pharma/02pharma-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/07/02/us/02pharma/02pharma-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/07/02/business/brand-name-drug-makers-wary-of-letting-generic-rival-join-their-club.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Pharmaceutical Research and Manufacturers of America", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Generic Brands and Products", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Inventions and Patents", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Lobbying and Lobbyists", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}], "blog": [], "_id": "5776e05e38f0d81f396c0469", "source": "The New York Times"}